Clinical Trials
36 trialsAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
University of Pittsburgh
SAH
Ruijin Hospital
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer
Blokhin's Russian Cancer Research Center
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
Accent Therapeutics
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
KEYNOTE 158
Merck Sharp & Dohme LLC
National Cohort of Colorectal Cancers With Microsatellite Instability
Federation Francophone de Cancerologie Digestive
NIPICOL
GERCOR - Multidisciplinary Oncology Cooperative Group
START-001
Marengo Therapeutics, Inc.
BLOOMSI
OncoAtlas LLC
PREMICES
GERCOR - Multidisciplinary Oncology Cooperative Group
INFINITY
Gruppo Oncologico del Nord-Ovest
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
WellSpan Health
M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability
M.D. Anderson Cancer Center
Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
University of Southern California
AuspiCiOus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Fate Therapeutics
POLEM
Royal Marsden NHS Foundation Trust
The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation
Affiliated Hospital of Qinghai University
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
Incyte Corporation
MSI-CRC
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Incyte Corporation
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact
Assistance Publique - Hôpitaux de Paris
Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study
V.K.V. American Hospital, Istanbul
MSI in Circulatory DNA of Endometrial Cancer
Peking Union Medical College Hospital
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
Shanghai Minimally Invasive Surgery Center
Molecular Biology of Anal Cancer in HIV-Positive Patients
University Hospital, Geneva
Implementation of a New Strategy to Identify HNPCC Patients
Radboud University Medical Center
Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
Radboud University Medical Center
Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan
National Taiwan University Hospital
Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer
National Taiwan University Hospital